NUP214 and acute myeloid leukemia: 5.9. The Possible Prognostic Impact of the DEK-NUP214 Fusion Pediatric AML Patients Receiving Intensive Antileukemic Adverse Prognosis Improved by Allogeneic Stem Cell Transplantation